243 related articles for article (PubMed ID: 6438244)
1. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
2. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
3. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
4. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
5. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
7. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.
Ferrari MJ; Fermon F; Nackers F; Llosa A; Magone C; Grais RF
Int Health; 2014 Dec; 6(4):282-90. PubMed ID: 25193978
[TBL] [Abstract][Full Text] [Related]
8. Control of epidemic meningococcal meningitis by mass vaccination.
Mohammed I; Zaruba K
Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
[No Abstract] [Full Text] [Related]
9. Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy.
Binkin N; Band J
Lancet; 1982 Aug; 2(8293):315-8. PubMed ID: 6124726
[TBL] [Abstract][Full Text] [Related]
10. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
Robbins JB; Towne DW; Gotschlich EC; Schneerson R
Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
[TBL] [Abstract][Full Text] [Related]
11. A severe epidemic of meningococcal meningitis in Nigeria, 1996.
Mohammed I; Nasidi A; Alkali AS; Garbati MA; Ajayi-Obe EK; Audu KA; Usman A; Abdullahi S
Trans R Soc Trop Med Hyg; 2000; 94(3):265-70. PubMed ID: 10974995
[TBL] [Abstract][Full Text] [Related]
12. Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
Ajibola O; Omoleke SA; Omisakin OA
Vaccine; 2018 Mar; 36(11):1423-1428. PubMed ID: 29426659
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
Miller MA; Wenger J; Rosenstein N; Perkins B
Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
[TBL] [Abstract][Full Text] [Related]
14. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
[TBL] [Abstract][Full Text] [Related]
15. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C
PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549
[TBL] [Abstract][Full Text] [Related]
16. Epidemic meningococcal meningitis in central Australia, 1987-1991.
Patel MS; Merianos A; Hanna JN; Vartto K; Tait P; Morey F; Jayathissa S
Med J Aust; 1993 Mar; 158(5):336-40. PubMed ID: 7605395
[TBL] [Abstract][Full Text] [Related]
17. Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt.
Chippaux JP; Campagne G; Djibo S; Cissé L; Hassane A; Kanta I
Ann Trop Med Parasitol; 1999 Jul; 93(5):505-10. PubMed ID: 10690246
[TBL] [Abstract][Full Text] [Related]
18. Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009.
Bassey BE; Vaz RG; Gasasira AN; Braka F; Weldegriebriel G; Komakech W; Toritseju MS; Fatiregun AA; Okocha-Ejeko A
Int J Infect Dis; 2016 Feb; 43():62-67. PubMed ID: 26724773
[TBL] [Abstract][Full Text] [Related]
19. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
Greenwood BM
Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
[TBL] [Abstract][Full Text] [Related]
20. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
Sante; 2003; 13(4):215-23. PubMed ID: 15047438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
